Competences to innovate in the pharmaceutical industry : the case of Fundação Oswaldo Cruz and the Instituto de Tecnologia em Farmacos / Competencias para inovar no setor farmaceutico : o caso da Fundação Oswaldo Cruz e de seu Instituto Tecnologico em Farmacos/ Far-Manguinhos

AUTOR(ES)
DATA DE PUBLICAÇÃO

2005

RESUMO

Product and process innovation is acknowledged as crucial for the competitiveness of countries and firms and seems to depend on a conjunction of factors that go far beyond the stricttechnologica1 capabi1ity (or technical change). This study has as its purpose to understand and describe the competencies that are essential to arrive at innovation in the pharmaceutical industry - specially technological, organizational, relational, productive and of means - having as a basic framework analytical structures that were recent1y developed in the literature as to the development and accumulation of competences and learning processes. In trying to ana1yze the competencies necessary 50 that a new chemical entity and a new drug reaches the market one has used a model that could be called "new drug discovery, development and commercialization cycle" as well as the chemical synthesis route. In so doing, one has described technological steps or stages, the chain of production, the value curve and the evolution of the technologies in pharmaceutical experimentation, as well as the main changes that have been occurring in this industry nowadays. The thesis studies the case of Fundação Oswaldo Cruz - Brasil (Oswaldo Cruz Foundation-Brazil), an institution devoted to Science and Technology in Hea1th that is sui generis in the Brazilian pharmaceutical environment and of its re1atedPharmaceutica1 Technology Institute- Far-Manguinhos, a public laboratory that fabricates drugs as a member of the official network (the on1y laboratory with this status) of the Ministry of Health in Brazil. As a result of the study, one describes the technological and institutional trajectory of Far-Manguinhos and a1so how the institution has arrive data technologica1 and managerial leapfrogging -in over little more than two decades. This technological learning process was made through the process of reversa1 engineering (a copy) of anti-retrovirals - thus giving conditions to the Ministry of Health to promote strong access of the . population to essential medicines (specific strategic programs of public hea1th, such as that of AIDS, stay as an important example) and thus saving substantial foreign reserves and guaranteeing effectiveness to the fight against disease in Brazil. One has arrived at the conc1usion that at Fiocruz one can identify the most part of needed competencies to innovate but one could also see that such competencies are not particularly integrated to the point of making emerge aradica1 innovation (farmaco or innovative drug)

ASSUNTO(S)

industrial research industria farmaceutica - inovações tecnologicas pharmaceutical industry medicamentos pesquisa industrial drugs pesquisa e desenvolvimento research and development

ACESSO AO ARTIGO

Documentos Relacionados